Abstract:Research purpose: The low treatment effectiveness in major depressive disorder (MDD) may be caused by the subjectiveness in clinical examination and the lack of quantitative tests. Objective biomarkers derived from magnetic resonance imaging (MRI) may support clinical experts during decision-making. Numerous studies have attempted to identify such MRI-based biomarkers. However, the majority is uni-modal (based on a single MRI modality) and focus on either MDD diagnosis or outcome. Uncertainty remains regarding whether key features or classification models for diagnosis may also be used for outcome prediction. Therefore, we aim to find multi-modal predictors of both, MDD diagnosis and outcome. By addressing these research questions using the same dataset, we eliminate between-study confounding factors. Various structural (T1-weighted, T2-weighted, diffusion tensor imaging (DTI)) and functional (resting-state and task-based functional MRI) scans were acquired from 32 MDD and 31 healthy control (HC) subjects during the first visit at the investigational site (baseline). Depression severity was assessed at baseline and 6 months later. Features were extracted from the baseline MRI images with different modalities. Binary 6-months negative and positive outcome (NO; PO) classes were defined based on relative (to baseline) change in depression severity. Support vector machine models were employed to separate MDD from HC (diagnosis) and NO from PO subjects (outcome). Classification was performed through a uni-modal (features from a single MRI modality) and multi-modal (combination of features from different modalities) approach. Principal results: Our results show that DTI features yielded the highest uni-modal performance for diagnosis and outcome prediction: mean diffusivity (AUC (area under the curve) = 0.701) and the sum of streamline weights (AUC = 0.860), respectively. Multi-modal ensemble classifiers with T1-weighted, resting-state functional MRI and DTI features improved classification performance for both diagnosis and outcome (AUC = 0.746 and 0.932, respectively). Feature analyses revealed that the most important features were located in frontal, limbic and parietal areas. However, the modality or location of these features was different between diagnostic and prognostic models. Major conclusions: Our findings suggest that combining features from different MRI modalities predict MDD diagnosis and outcome with higher performance. Furthermore, we demonstrated that the most important features for MDD diagnosis were different and located in other brain regions than those for outcome. This longitudinal study contributes to the identification of objective biomarkers of MDD and its outcome. Follow-up studies may further evaluate the generalizability of our models in larger or multi-center cohorts.

Discriminating subclinical depression from major depression using multi-scale brain functional features: A radiomics analysis

Classification and Interpretability of Mild Cognitive Impairment Based on Resting-State Functional Magnetic Resonance and Ensemble Learning.

A two-center radiomic analysis for differentiating major depressive disorder using multi-modality MRI data under different parcellation methods

Biotypes of major depressive disorder: Neuroimaging evidence from resting-state default mode network patterns.

Classification of Unmedicated Bipolar Disorder Using Whole-Brain Functional Activity and Connectivity: A Radiomics Analysis.

Resting-State Functional Magnetic Resonance Image to Analyze Electrical Biological Characteristics of Major Depressive Disorder Patients with Suicide Ideation

Common and unique neural activities in subclinical depression and major depressive disorder indicate the development of brain impairments in different depressive stages

Intelligent classification of major depressive disorder using rs-fMRI of the posterior cingulate cortex

Classification of Depressive Disorder Based on RS-fMRI Using Multivariate Pattern Analysis with Multiple Features

Discriminative Analysis of Depression Patients Studied with Structural MR Images Using Support Vector Machine and Recursive Feature Elimination

Quantitative Identification of Major Depression Based on Resting-State Dynamic Functional Connectivity: A Machine Learning Approach.

Sleep Disturbance-Related Neuroimaging Features As Potential Biomarkers for the Diagnosis of Major Depressive Disorder: A Multicenter Study Based on Machine Learning

Disease Definition for Schizophrenia by Functional Connectivity Using Radiomics Strategy

Diagnosis of Major Depressive Disorder Using Machine Learning Based on Multisequence MRI Neuroimaging Features

A Novel MSN-II Feature Extracted from T1-weighted MRI for Discriminating Between BD Patients and MDD Patients

Discriminative analysis of schizophrenia and major depressive disorder using fNIRS

Aberrant functional connectivity and activity in Parkinson's disease and comorbidity with depression based on radiomic analysis

Differentiating Parkinson's disease motor subtypes: A radiomics analysis based on deep gray nuclear lesion and white matter

Multi-modal MRI for objective diagnosis and outcome prediction in depression

Radiomics Analysis of Magnetic Resonance Imaging Facilitates the Identification of Preclinical Alzheimer’s Disease: An Exploratory Study

Multivariate Machine Learning Analyses in Identification of Major Depressive Disorder Using Resting-State Functional Connectivity: A Multicentral Study